Green Tea's Impact on Blood Viscosity in Healthy Adults
Green Tea
+ Control (Hot Water)
Cardiovascular Diseases
Prevention Study
Summary
Study start date: January 1, 2025
Actual date on which the first participant was enrolled.This study aims to explore how consuming green tea might affect the thickness and flow of blood, known as blood viscosity, in healthy individuals. It specifically targets non-smokers without a history of cardiovascular disease or metabolic disorders, who are also not taking any heart-related medications. This research is important because understanding how green tea impacts blood viscosity could offer insights into its potential benefits for heart health, potentially leading to new dietary recommendations for preventing cardiovascular issues. Participants in this study undergo a series of tests and follow specific dietary restrictions before their participation. Initially, participants are required to provide a blood sample and undergo various health checks. They then consume 200 mL of green tea, with blood samples taken before and at two intervals after consumption to assess changes in blood viscosity. A second visit involves repeating the procedure with hot water instead of green tea to serve as a control. The study also includes a questionnaire about dietary habits and hydration levels, with participants asked to maintain certain routines to ensure consistent results.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.35 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Hugh Sinclaire Unit of Human Nutrition, Departmeant of Food and Nutrition, University of Reading
Reading, United KingdomOpen Hugh Sinclaire Unit of Human Nutrition, Departmeant of Food and Nutrition, University of Reading in Google Maps